Literature DB >> 24068586

Expression and role of grainyhead-like 2 in gastric cancer.

Jifeng Xiang1, Xiang Fu, Wenhua Ran, Xuan Chen, Zhen Hang, Hongchao Mao, Ziwei Wang.   

Abstract

The aim of this study was to evaluate the expression and role of Grhl2 in gastric cancer. Immunohistochemistry was performed to explore the expression of Grhl2 in gastric cancer and surrounding non-tumor tissues. Moreover, the mRNA and protein expression level of Grhl2 in human immortalized gastric epithelial cell line GES-1 and four gastric cancer cell lines (MGC803, SGC7901, MKN45, HGC27) were detected by qRT-PCR and Western blotting, respectively. To further investigate the role of Grhl2 in gastric cancer as well as the potential mechanisms, SGC7901 cells were transfected with lentiviral constructs expressing Grhl2 or empty vector, and then proliferation and apoptosis of SGC7901 cells were evaluated by MTT assay and flow cytometry, respectively. Finally, the protein expression level of c-Myc and Bcl-2 was detected by Western blotting. Both mRNA and protein expression level of Grhl2 were significantly downregulated in gastric cancer. Exogenous Grhl2 transduced into SGC7901 cells significantly inhibited the proliferation and promoted apoptosis. Meanwhile, over-expression of Grhl2 decreased c-Myc and Bcl-2 protein expression level. Taken together, our results demonstrated that Grhl2 downregulated in gastric cancer and may function as a tumor suppressor and play an important role in the development and progression of gastric cancer. These results may provide a new clue for treatment for gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24068586     DOI: 10.1007/s12032-013-0714-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  The Grainyhead transcription factor Grhl3/Get1 suppresses miR-21 expression and tumorigenesis in skin: modulation of the miR-21 target MSH2 by RNA-binding protein DND1.

Authors:  A Bhandari; W Gordon; D Dizon; A S Hopkin; E Gordon; Z Yu; B Andersen
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

3.  Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors.

Authors:  Goodarz Danaei; Stephen Vander Hoorn; Alan D Lopez; Christopher J L Murray; Majid Ezzati
Journal:  Lancet       Date:  2005-11-19       Impact factor: 79.321

4.  Spatial and temporal expression of the Grainyhead-like transcription factor family during murine development.

Authors:  Alana Auden; Jacinta Caddy; Tomasz Wilanowski; Stephen B Ting; John M Cunningham; Stephen M Jane
Journal:  Gene Expr Patterns       Date:  2006-04-25       Impact factor: 1.224

5.  Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis.

Authors:  Charbel Darido; Smitha R Georgy; Tomasz Wilanowski; Sebastian Dworkin; Alana Auden; Quan Zhao; Gerhard Rank; Seema Srivastava; Moira J Finlay; Anthony T Papenfuss; Pier Paolo Pandolfi; Richard B Pearson; Stephen M Jane
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743

6.  Targeting p53 for Novel Anticancer Therapy.

Authors:  Zhen Wang; Yi Sun
Journal:  Transl Oncol       Date:  2010-02       Impact factor: 4.243

7.  Over-expression of Grhl2 causes spina bifida in the Axial defects mutant mouse.

Authors:  Madeleine R Brouns; Sandra C P De Castro; Els A Terwindt-Rouwenhorst; Valentina Massa; Johan W Hekking; Caroline S Hirst; Dawn Savery; Chantal Munts; Darren Partridge; Wout Lamers; Eleonore Köhler; Henny W van Straaten; Andrew J Copp; Nicholas D E Greene
Journal:  Hum Mol Genet       Date:  2011-01-24       Impact factor: 6.150

8.  Gene trapping identifies a putative tumor suppressor and a new inducer of cell migration.

Authors:  Francisca Guardiola-Serrano; Judith Haendeler; Margarete Lukosz; Karsten Sturm; Harald von Melchner; Joachim Altschmied
Journal:  Biochem Biophys Res Commun       Date:  2008-09-22       Impact factor: 3.575

Review 9.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

10.  The grainyhead like 2 gene (GRHL2), alias TFCP2L3, is associated with age-related hearing impairment.

Authors:  Lut Van Laer; Els Van Eyken; Erik Fransen; Jeroen R Huyghe; Vedat Topsakal; Jan-Jaap Hendrickx; Samuli Hannula; Elina Mäki-Torkko; Mona Jensen; Kelly Demeester; Manuela Baur; Amanda Bonaconsa; Manuela Mazzoli; Angeles Espeso; Katia Verbruggen; Joke Huyghe; Patrick Huygen; Sylvia Kunst; Minna Manninen; Annelies Konings; Amalia N Diaz-Lacava; Michael Steffens; Thomas F Wienker; Ilmari Pyykkö; Cor W R J Cremers; Hannie Kremer; Ingeborg Dhooge; Dafydd Stephens; Eva Orzan; Markus Pfister; Michael Bille; Agnete Parving; Martti Sorri; Paul H Van de Heyning; Guy Van Camp
Journal:  Hum Mol Genet       Date:  2007-10-06       Impact factor: 6.150

View more
  24 in total

Review 1.  Roles of Grainyhead-like transcription factors in cancer.

Authors:  S M Frisch; J C Farris; P M Pifer
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

2.  Grainyhead-like 2 downstream targets act to suppress epithelial-to-mesenchymal transition during neural tube closure.

Authors:  Heather J Ray; Lee A Niswander
Journal:  Development       Date:  2016-02-22       Impact factor: 6.868

Review 3.  Recent discoveries concerning the involvement of transcription factors from the Grainyhead-like family in cancer.

Authors:  Michal Mlacki; Agnieszka Kikulska; Ewa Krzywinska; Magdalena Pawlak; Tomasz Wilanowski
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-10

4.  Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1.

Authors:  Yingjun Quan; Runsen Jin; Ao Huang; Hongchao Zhao; Bo Feng; Lu Zang; Minhua Zheng
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

5.  Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.

Authors:  Adnen Faddaoui; Razan Sheta; Magdalena Bachvarova; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Stephane Gobeil; Chantale Morin; Karim Ghani; Dimcho Bachvarov
Journal:  Cell Cycle       Date:  2017-02-22       Impact factor: 4.534

6.  Stable Binding of the Conserved Transcription Factor Grainy Head to its Target Genes Throughout Drosophila melanogaster Development.

Authors:  Markus Nevil; Eliana R Bondra; Katharine N Schulz; Tommy Kaplan; Melissa M Harrison
Journal:  Genetics       Date:  2016-12-22       Impact factor: 4.562

7.  Expression of transcription factor grainyhead-like 2 is diminished in cervical cancer.

Authors:  Luis A Torres-Reyes; Liliana Alvarado-Ruiz; Patricia Piña-Sánchez; María G Martínez-Silva; Moisés Ramos-Solano; Vicente Olimón-Andalón; Pablo C Ortiz-Lazareno; Georgina Hernández-Flores; Alejandro Bravo-Cuellar; Adriana Aguilar-Lemarroy; Luis F Jave-Suarez
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 8.  Grainyhead-like 2 as a double-edged sword in development and cancer.

Authors:  Jiaxing He; Chunyang Feng; He Zhu; Shuying Wu; Peng Jin; Tianmin Xu
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

9.  Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.

Authors:  Wei Chen; Jin Kyu Yi; Tetsu Shimane; Shebli Mehrazarin; Yi-Ling Lin; Ki-Hyuk Shin; Reuben H Kim; No-Hee Park; Mo K Kang
Journal:  Carcinogenesis       Date:  2016-03-01       Impact factor: 4.944

10.  GRHL2 suppresses tumor metastasis via regulation of transcriptional activity of RhoG in non-small cell lung cancer.

Authors:  Xiang Pan; Rong Zhang; Caifeng Xie; Mingxi Gan; Sheng Yao; Yubin Yao; Jiangbo Jin; Tianyu Han; Yunhe Huang; Yanlong Gong; Jianbin Wang; Bentong Yu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.